Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
1501
Apollo Commercial Real Estate
ARI
$885M
| $5.46M | ﹤0.01% |
368,212
-9,947
| -3% | -$152K |
|
1502
FirstCash
FCFS
$8.78B
| $5.46M | ﹤0.01% |
62,400
+6,933
| +12% | +$573K |
|
1503
B&G Foods
BGS
$286M
| $5.45M | ﹤0.01% |
182,182
-16,832
| -8% | -$505K |
|
1504
Triumph Financial Inc
TFIN
$1.82B
| $5.42M | ﹤0.01% |
54,090
+6,377
| +13% | +$511K |
|
1505
BlackLine
BL
$1.72B
| $5.42M | ﹤0.01% |
45,872
+12,366
| +37% | +$1.42M |
|
1506
Cerence
CRNC
$414M
| $5.41M | ﹤0.01% |
56,324
+30,228
| +116% | +$3.3M |
|
1507
Healthcare Services Group
HCSG
$1.53B
| $5.38M | ﹤0.01% |
215,210
+109,070
| +103% | +$2.95M |
|
|
BPMC
1508
DELISTED
Blueprint Medicines
BPMC
| $5.37M | ﹤0.01% |
52,278
+10,807
| +26% | +$1.01M |
|
1509
Nexstar Media Group
NXST
$5.97B
| $5.37M | ﹤0.01% |
35,319
+3,601
| +11% | +$531K |
|
|
MODV
1510
DELISTED
ModivCare
MODV
| $5.35M | ﹤0.01% |
29,467
+2,809
| +11% | +$500K |
|
1511
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
| $5.35M | ﹤0.01% |
1,148,563
+57,566
| +5% | +$269K |
|
1512
NMI Holdings
NMIH
$3.36B
| $5.34M | ﹤0.01% |
236,355
+16,735
| +8% | +$368K |
|
|
B
1513
DELISTED
Barnes Group Inc.
B
| $5.34M | ﹤0.01% |
127,988
+5,690
| +5% | +$271K |
|
1514
CRISPR Therapeutics
CRSP
$5.17B
| $5.34M | ﹤0.01% |
47,691
+11,926
| +33% | +$1.5M |
|
|
CVSA
1515
Covista Inc
CVSA
$4.8B
| $5.34M | ﹤0.01% |
141,125
+60,741
| +76% | +$2.25M |
|
1516
Protolabs
PRLB
$2.13B
| $5.33M | ﹤0.01% |
79,989
+7,990
| +11% | +$624K |
|
1517
Monro
MNRO
$398M
| $5.32M | ﹤0.01% |
92,480
+6,685
| +8% | +$392K |
|
1518
Patrick Industries
PATK
$2.85B
| $5.31M | ﹤0.01% |
95,555
+9,642
| +11% | +$516K |
|
1519
CareDx
CDNA
$2.42B
| $5.3M | ﹤0.01% |
83,725
+16,697
| +25% | +$1.27M |
|
1520
Banner Corp
BANR
$2.4B
| $5.3M | ﹤0.01% |
95,984
+8,488
| +10% | +$457K |
|
1521
ACI Worldwide
ACIW
$5.42B
| $5.29M | ﹤0.01% |
172,305
+15,216
| +10% | +$505K |
|
1522
KB Home
KBH
$3.59B
| $5.28M | ﹤0.01% |
135,624
-2,378
| -2% | -$98.7K |
|
1523
Palomar
PLMR
$3.45B
| $5.24M | ﹤0.01% |
64,834
+11,011
| +20% | +$909K |
|
1524
Patterson-UTI
PTEN
$3.76B
| $5.24M | ﹤0.01% |
581,717
-41,128
| -7% | -$333K |
|
1525
Hain Celestial
HAIN
$53.7M
| $5.23M | ﹤0.01% |
122,269
-6,374
| -5% | -$252K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.